Leveraging open hardware to alleviate the burden of COVID-19 on global health systems by Maia Chagas, Andre et al.
COMMUNITY PAGE
Leveraging open hardware to alleviate the
burden of COVID-19 on global health systems
Andre Maia ChagasID1,2,3*, Jennifer C. MolloyID3,4*, Lucia L. Prieto-GodinoID2,5,6*,
Tom BadenID1,2,6,7*
1 Sussex Neuroscience, School of Life Sciences, University of Sussex, Brighton, United Kingdom, 2 TReND
in Africa, Brighton, United Kingdom, 3 Gathering for Open Science Hardware, 4 Department of Chemical
Engineering and Biotechnology, University of Cambridge, Cambridge, United Kingdom, 5 The Francis Crick
Institute, London, United Kingdom, 6 FENS-KAVLI Network of Excellence, 7 Institute for Ophthalmic
Research, University of Tu¨bingen, Tu¨bingen, Germany
* a.maia-chagas@sussex.ac.uk (AMC); jcm80@cam.ac.uk (JCM); lucia.prietogodino@crick.ac.uk (LLPG); t.
baden@sussex.ac.uk (TB)
Abstract
With the current rapid spread of COVID-19, global health systems are increasingly overburdened
by the sheer number of people that need diagnosis, isolation and treatment. Shortcomings are
evident across the board, from staffing, facilities for rapid and reliable testing to availability of hos-
pital beds and key medical-grade equipment. The scale and breadth of the problem calls for an
equally substantive response not only from frontline workers such as medical staff and scientists,
but from skilled members of the public who have the time, facilities and knowledge to meaning-
fully contribute to a consolidated global response. Here, we summarise community-driven
approaches based on Free and Open Source scientific and medical Hardware (FOSH) as well
as personal protective equipment (PPE) currently being developed and deployed to support the
global response for COVID-19 prevention, patient treatment and diagnostics.
Introduction
In recent days and weeks, governments around the world have called upon industry to address
key shortcomings in the global response to COVID-19—for example to produce more per-
sonal protective equipment (PPE), ventilators and diagnostic tools [1,2]. While this is an
important part of any country’s response, the capacity of existing industry to meet the scale of
the challenge is likely insufficient [3–5]. Moreover, this approach will first address shortages
locally where relevant industry is based, rather than globally, and medical grade equipment
and kits emerging from this process will be costly, at a time where the economy is taking a big
hit. Clearly, product innovation and novel manufacturing pipelines are required.
Here, one complementary access route to much needed tools and equipment is Free and
Open Source (scientific and medical) Hardware (FOSH). FOSH follows the ethos of open
source software, where all blueprints for a tool are made freely available under appropriate
licenses so that anyone can study, learn, modify, customize and commercialize them [6,7].
Studies and practical experience with FOSH have shown key benefits that are paramount for
disaster situations: fast and distributed development based on the contributions of many
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people who are for the most part working remotely [8,9].This is advantageous given the social
distancing measures in place in many COVID-19 affected countries. The typically much lower
implementation costs of FOSH [10] and easy adaptability to local resources are key further
benefits of an open hardware approach.
Finally, and perhaps most importantly, any new hardware designs or improvements thereof
are by their very definition globally available. Anyone equipped with the necessary knowhow,
tools and time can build on this knowledge to meaningfully support their immediate commu-
nity. The importance of the latter cannot be overstated: Different communities face different
limitations in the availability of trained staff, medical consumables and machines as well as
diagnostic tools. Accordingly, what may be limiting in one place may not be limiting in the
next, and any global response must therefore be adjusted to local realities. Here, the many ben-
efits of a FOSH approach allow for fast, local deployment which can bypass traditional produc-
tion chains to flexibly supply affected areas as they emerge. While this is useful worldwide, it
may be particularly important for regions that traditionally have fewer communication links
and/or where the medical and scientific infrastructure is generally less well developed [11].
A FOSH approach to supporting global health systems
Increasingly over recent years, scientists, engineers and hobbyists alike have jointly developed
and tested an impressive array of open source and state-of-the art tools that in one way or
another touch all aspects of modern biology, medicine and disaster response (e.g., [12–23]).
For example, in the wake of the 2011 Fukushima nuclear disaster, Safecast [9] developed
FOSH Geiger counters alongside an open access logging system which led to a massive citizen-
science driven map of nuclear contamination in the region [9]. Now the same group is step-
ping up to meet the challenges of COVID-19 [24]. Other community driven FOSH designs rel-
evant to the current situation range from simple tools like DIY masks [25,26] or 3D printed
valves to regulate airflow in ventilator tubes [27] to state-of-the-art scientific instruments for
diagnosis such as an automated pipetting robot [28], plate readers [29] as well as a wide range
of medical tools and supplies [22]. Diverse further initiatives, including numerous designs for
FOSH ventilators [30–38], are well underway. Here, we provide a brief overview of the current
state-of-the art in available designs and ongoing community projects aiming to leverage FOSH
to meaningfully contribute to a global response to the current crisis (see also Box 1). In the spe-
cific background of COVID-19, we highlight a subset of available projects centered around:
Box 1. An important note of caution and disclaimer
An important note of caution: When implementing any of the projects mentioned in
this article, it is important to critically evaluate the reliability and safety of the design on
a case by case basis. While some designs have been extensively tested and verified, others
are at best anecdotally verified and are intended for research use only. While this is
important in all aspects of FOSH, it becomes imperative when considering diagnostic
and medical tools. This should also include careful reference to regulations on control
softwares, where applicable [41]. Use of these designs in a clinical setting may be prohib-
ited by local regulations. Notably, the US National Institutes of Health (NIH) 3D print
exchange collects a list of designs that have been approved for clinical use in at least one
hospital [42].
Disclaimer: The introductory notes on masks and ventilators are based on available lit-
erature. The authors have no formal medical training.
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1. Personal protective equipment (PPE) such as masks and visors
2. Patient treatment, focussing on ventilators
3. Diagnosis tools, focussing on scientific equipment and test-kits
Although several projects are listed here, interested readers can find curated lists online that
are being updated on a daily basis. At the time of writing these were available [36,39,40]
Building personal protective equipment (PPE)
Buying a facemask off the shelf is becoming increasingly difficult, and people are understand-
ably looking into do-it-yourself (DIY) options that may serve as a useful replacement. Simi-
larly, hospitals are running out of specialised personal protective equipment (PPE) for medical
staff, which typically includes both a mask and a visor, alongside specialised clothing and
gloves. Here, we will focus on DIY masks and visors (Fig 1, Table 1).
First, it is important to consider what level of protection is required. For example, masks
come in many varieties, with different purposes and regulatory standards [48–51]. Some sim-
pler masks (often called surgical masks) are intended to be used by the infected person to
reduce spread of infection by catching large droplets, for example after coughing and sneezing.
Such masks are fairly easily home-fashioned (e.g. [52], Table 1A), but they are not generally
Fig 1. Examples of DIY masks and visors. A, One of many designs for a home-made cloth-mask [43], which to date remain generally untested for
effectiveness. B, Somewhat more effective cotton T-shirt based mask [25], C, Impermeable mask cover [44]. D, Stop gap surgical mask (3D printed)
[45]. E, Laser-cut face-shield [46]. F, Aerosol box [47].
https://doi.org/10.1371/journal.pbio.3000730.g001
PLOS BIOLOGY
PLOS Biology | https://doi.org/10.1371/journal.pbio.3000730 April 24, 2020 3 / 17
thought of as an effective form of protection from becoming infected in the first place
[21,22,35]. Nonetheless, it has been argued that they can reduce the spread of viral particles
from infected persons [53]. A recent influential paper [54] elaborated on this point, however
this study did not look at SARS-CoV-2, nor at possible spread from asymptomatic carriers (see
also [55]). Another study, with four COVID-19 patients, found surgical masks to be ineffective
in preventing the spread of SARS-CoV2 [56]. Whether or not the general public should be
advised to use surgical-type masks, and under which specific circumstances, is a matter of
ongoing debate. At time of writing, the World Health Organisation (WHO) advises:
• If you are healthy, you only need to wear a mask if you are taking care of a person with sus-
pected 2019-nCoV infection.
Table 1. Open source and do-it-yourself personal protective equipment. Highlighted are masks, face shields and aerosol boxes.
Project Name License Type Note
A, Surgical-type masks
Simple respiratory mask N/A Tied Peer reviewed open access paper
3D printed face mask from la factoria 3d CC-BY-NC (?) 3D printed license from https://www.thingiverse.com/thing:4225667
Stopgap surgical face mask CC-BY 3D printed 3D printed mask that has undergone clinical testing
Montana Mask N/A 3D printed Shares more than stl files for 3D printings
EDAGmask4all N/A 3D printed Mask clips to hold textile in place. Only stls are available
Bra face mask N/A Sewn Masks made out of bras.
CDC face masks N/A Sewn Cloth masks, CDC tutorial
Cloth mask with filter N/A Sewn Cloth masks, Georgia Tech tutorials
DIY 2 layer cloth mask N/A Sewn Cloth mask with 2 layers
DIY sewn facemask N/A Sewn Cloth mask
How to sew a face mask N/A Sewn Video tutorial
Maker Masks CC BY 4.0 Sewn Multiple designs including a mask protector
Paper towel mask CC BY 3.0 Paper towel Paper towel mask
B, N95-type masks
Project 1000X1000 CC-BY-NC 4.0 Filter production Initiative to produce air filters for masks
License limits legal use in several places
Copper 3D CC-BY-NC 4.0 3D printed License limits legal use in several places
Only sharing STL files
N95decon Copyright Test/study
consortium
"A scientific consortium for data-driven study
of N95 filtering facepiece respirator decontamination"
Pneumask CC-BY-NC-SA 4.0 Snorkel mask License limits legal use in several places
C, Face protectors
Origami Droplet Face-Shield CC-BY-SA 4.0 Laser cut Shield using only laser cut parts
Proto-shield CC-BY-SA Laser cut Shield using only laser cut parts
GliaX face protector GNU-GPL 3.0 3D printed + sheet
Prusa face protector CC-BY-NC 4.0 3D printed + sheet License limits legal use in several places
Georgia Tech face shields N/A Injection mold
Face protector w/o 3D print/laser cut N/A Glued
U. Wisconsin-Madison face shield N/A Glued
Face protector from water bottle N/A Cut-out
Prusa face protector disinfection tests Copyright Disinfection tests Copyright is for webpage. N/A about project license
D, Other PPE
Aerosol box CC-BY-NC 4.0 License limits legal use in several places.
Aerosol container CC-BY-NC 4.0 Based on aerosol box listed above
Barrier enclosure for endotracheal intubation Copyright
https://doi.org/10.1371/journal.pbio.3000730.t001
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• Wear a mask if you are coughing or sneezing.
For an up-to-date summary on the role and use of various types of masks, the reader is
referred to their official advice [57]. Notably, the Centre for Disease Control (CDC) in the
USA currently recommends wearing masks in public settings where other social distancing
measures are difficult to maintain, especially in areas of significant community-based trans-
mission [58]. Moreover, it is possible, and arguably likely, that others will follow suit, especially
as the world reopens.
In contrast to surgical masks, so called N95 filtering facepiece respirators (FFRs) are
intended to provide a high level of protection to the wearer, and they are for example used by
medical staff tending to infected patients. Unlike surgical masks, these are designed to seal
against air slipping through gaps between the skin and the mask, and they contain a specialised
filter that acts as a physical barrier to particles down to 0.3 microns. This is still bigger than the
actual virus (~0.12 microns) [59], but substantially smaller than most droplets coming off a
sneeze or cough. The performance standards for such masks are tightly regulated [48–51], and
any DIY approach to replicating them must take careful reference to these regulations, which
may also vary locally. Accordingly, controlled testing of existing and upcoming N95-like FFR
prototypes is paramount. Moreover, unless worn correctly they may end up being no more
useful than a surgical mask [57]. For protecting the eyes, N95s can be combined with tight-fit-
ting goggles, or a face shield.
Right now there are many DIY designs for various types of masks out there, from simple
video tutorials based on napkins, cloth or bra-cups (Table 1A) [60–62] via 3D printed options
[63] to designs developed and/or tested in peer-reviewed scientific studies [25,26] (Fig 1).
Some are quite effective [25], however to our knowledge to date none fully comply with regula-
tory standards. Nonetheless, with designs currently being published on a daily basis, this may
soon change. Table 1B summarises a subset of DIY N95 projects available at time of writing.
Alternatively, medical staff also use splash-resistant surgical masks (IIR, resistant at 160
mmHg), together with a face shield [42]. The latter combination may be easier to build to reg-
ulatory standards than N95 masks [56], in part because they do not need to seal tightly against
the skin. An online search quickly reveals several designs of face shields (and IIRs [44]) with
varying levels of associated testing [64,65] (Table 1C, Fig 1E). For example, 3D Crowd is a UK-
based citizen network that is mobilizing volunteers to produce and deliver DIY face protectors
to hospitals and health institutions [66]. Through “The Big Print” they have gathered requests
for 370,000 units. 80,000 of them are in production by currently over 5,500 volunteers. An
alternative approach is based on existing full-face snorkel masks [67] which would effectively
serve as a combined mask and visor. Efforts such as these, including their important experi-
mental verification, could easily be scaled with minimal investment. They may also be more
easily disinfected for reuse compared to masks [68,69].
In addition, more specialised PPE is also being actively developed. This includes DIY test-
ing booths for diagnostics (virus inactivation before testing needs to be done in a biosafety
level 2 facility, BSL2, see below) and DIY aerosol boxes, which are for example used when intu-
bating patients (Fig 1F, Table 1D). Like all medical equipment, these also require regulatory
approval [48–51].
Choice of building materials for PPE
Building materials should be carefully considered. For example, it has been argued that the
porosity of 3D printed materials could make them a risky choice for masks as they may allow
viral droplets to persist for prolonged periods of time [68]. Possible gaps in the material itself
(e.g. due to blistering or imperfect layering during printing) add further room for concern. At
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the time of writing, we are not aware of available data on the above points. Similarly, when
laser cutting parts the use of acrylics should be carefully weighed against the need to sanitize it
using alcohols or oxygen peroxide which can react with the acrylic. If available, and if the laser
cutter at hand can handle it (many cannot), polycarbonate or polyethylene terephthalate glycol
(PETG) sheets may present a safer choice. A guide to disinfecting DIY PPE can be found here
[70]. Throughout, it also remains important to consider possible quality variations due to the
building process itself.
FOSH Ventilators
Ventilators are medical devices that support or take over patient respiration by delivering air
or other gas mixtures. Patients able to breathe on their own are often treated supported by a
constant airflow through cannulas or positive pressure masks (PPMs). In more severe cases
patients are intubated (insertion of a tube into the patient’s airway). Here, some modern venti-
lators can synchronise the release of gases to any remaining natural breathing attempts. In
other cases, ventilators can take over entirely (usually combined with patient sedation).
Towards the end of treatment, patients must be carefully weaned off the ventilator. Generally,
the use of ventilators brings about risks for infections including pneumonia, lung damage and
oxygen toxicity. The latter two of which can sometimes be linked to improper use of the device
(e.g. excess air pressure and/or oxygen concentration).
From a technical point of view, ventilators can be as simple as manually operated compress-
ible bags (bag valve masks—BVM), or as complex as fully computerized machines that regulate
gas pressure, humidity, gas relative concentrations as well as cycle rate, while taking real-time
measurements to monitor patient condition. This added complexity of some more modern
systems makes them more suitable for prolonged use, as they better mimic physiological con-
ditions and can be adjusted to specific patient needs. The NIH provides a general overview on
ventilators and their use [71], including a wide range of interface types, ventilator functions
and other details that are not covered in this article.The UK also recently published their own
specifications for ventilators to be used in hospitals [72].
The use of non-invasive systems for patients with COVID-19 in hospitals is currently
debated due to their potential to create aerosols which increase the risk of infecting others
[73]. Nonetheless some have argued they may have a place under certain circumstances [74],
and it is moreover possible that such systems may come into increased use as the situation
worsens. However, only invasive systems can fully take over respiration where required.
Already now, and likely more so in the near future, availability of ventilators for patient
care is limiting [75–77]. Current efforts to address this impasse include the stopping of elective
surgeries to free up existing systems [78], the recommissioning of disused models from stor-
age, and a plea to industry to ramp up production [1,79]. In parallel, diverse groups around
the world are rallying their communities to design FOSH-solutions that will help increase the
availability of ventilators (Fig 2, Table 2). Some examples include the development of complete
and stand-alone systems [80,81], the automation of manual ventilators [31,33,37] and the
repair of existing but out-of-use equipment, e.g. with 3D printed replacement parts [82,83].
Many projects are actively looking for collaborators with various backgrounds. FOSH ventila-
tors for invasive use will need to implement feedback systems based on sensors that measure
pressure, CO2 and oxygen levels, tidal and dead space volumes, and air humidity. These are
necessary measurements to know if the machine is doing what is supposed to, and that it is not
causing even more harm to the patient.
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FOSH approaches in COVID-19 diagnostics
The WHO recommends that countries should prioritize case finding, testing and isolation as a
main strategy to slow down the spread of the virus [87]. This means that testing must be made
widely available. The diagnosis of SARS-CoV-2 involves sample collection, usually from naso-
pharyngeal or oropharyngeal swabs [87], followed by RNA extraction as SARS-CoV-2 is an
RNA virus. This typically involves binding the RNA onto silica in specific buffers followed by
washing and resuspension. Then, the viral RNA is specifically amplified after reverse transcrib-
ing it to DNA. Finally the presence of this DNA is detected, usually by measuring changes in
fluorescence intensity or colour. The most common diagnostic procedure involves the use of a
commercial kit for RNA extraction, followed by quantitative Reverse Transcription Polymer-
ase Chain Reaction (qRT-PCR) [88] which requires several types of hardware, chemicals and
reagents to be deployed and typically takes place in a regulated lab that meets ISO 15189 stan-
dards for diagnostics [89]. In addition, RNA extraction or virus inactivation before RNA
extraction elsewhere must take place in a BSL2 facility (see above for FOSH PPE designed to
substitute a BSL2 facility).
Central testing labs overwhelmingly use automated sample extraction systems and other
hardware that have been validated by the FDA and CDC in the US or the national equivalent
Fig 2. Examples of FOSH ventilators. A, Arduino based PPM system [31]. B, Pandemic ventilator derivative [84]. C, OxyGEN bag automation system [37], D,
Prototype rendering from Open Source Ventilator initiative [85]. E, PPM ventilator based on snorkel mask and 3D printed adaptor [86].
https://doi.org/10.1371/journal.pbio.3000730.g002
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in their local jurisdiction. These are supplied by a small number of large companies (e.g. Qia-
gen, Roche and Abbott) with vertically integrated business models: only proprietary reagent
cartridges and plastic pipette tips for processing samples will typically fit the instruments and
there are no or few generic suppliers. This is one of the reasons for acute shortages that have
led to calls for donations of reagents and instruments from academic labs to bolster public
health efforts [105].
There has also been unprecedented rapid and open sharing of diagnostics and devices
through preprint publications, and through informal communication routes among research-
ers [90,106–108]. For example, agencies in China, Germany, Hong Kong, Japan, Thailand,
South Africa and the United States have shared protocols for molecular assays online, includ-
ing the DNA sequences to detect the virus. Others are now reproducing these in their own labs
as well as commercially [88,109]. Meanwhile, large sums of money are being invested in uni-
versities, public hospitals and the private sector to develop rapid point-of-care (POC) or near-
POC devices to enable scaling of testing in clinics, temporary facilities and even homes.
All reagents and devices used for diagnostics are typically regulated in terms of their manu-
facture and use, meaning that “home-brew” or DIY solutions are typically not acceptable
unless the lab developing and using them is itself certified, and then only under certain condi-
tions. In some jurisdictions regulations are becoming simpler or accelerated during the
Table 2. Open source ventilators and positive pressure masks.
Project Name License Type Note
Ventilators
Open ventilator system initiative CERN-OHL v2.0 Ventilator Documentation to be released
Reesistencia GNU-GPL 3.0 Ventilator Advanced testing stage, updates regularly:
https://twitter.com/ReesistenciaT?s=09
Inspire-OpenLung CERN-OHL v2.0 Ventilator Brazilian project, most documentation in Portuguese
CITI-OpenLung CERN-OHL v2.0 Ventilator Brazilian project, fork of "Inspire" above
Electro´nica Reespirator23-17 MIT / CC-BY-NC 4.0 Ventilator Repository is licensed with MIT, but design files are CC-BY-NC 4.0
Open Vent Permissive coypright (?) Ventilator Started as part of the WirvsVirus hackathon
MUR GNU GPL 3.0 Ventilator Project in French
E-Vent Not released yet Ventilator From MIT. No designs have yet been published.
Open Ventilator N/A Ventilator
Open Source Ventilator Ireland GNU-GPL 3.0 Ventilator
Open Lung GNU-GPL 3.0 Ventilator Canadian project working with Irish Open Source Ventilator above
Take a breather (TAB) N/A Ventilator
The Pandemic Ventilator N/A Ventilator One of oldest projects, before "reactivation" posts date back to 2011
Pandemic ventilator 2.0 N/A Ventilator Pandemic ventilator spin off
Proyecto PVPv1.2 N/A Ventilator Pandemic ventilator spin off, based in Argentina
Oxygen N/A Ventilator Spanish project with two versions: one for makers, one for industry
RespiraWorks N/A Ventilator Project to document ventilators designs
Ventilator firmware MIT Ventilator Brazilian project developing a universal firmware for ventilators
Medtronic ventilator Custom license Ventilator License only allows use while WHO PHEIC is in place or Oct 2024
Oxvent N/A Ventilator No designs available yet. Ventilator in testing phase in the UK.
Vent4us N/A Ventilator Documentation to be released
PAPR MIT PPM Ventilator
Mechanical ventilator Milano N/A PPM Ventilator
Illinois rapid vent Custom license PPM Ventilator Requires signature of license form
Isinnova Easy covid 19 N/A PPM Ventilator Positive pressure mask (PPM)
Ifixit repair guides CC Ventilator repair guide
https://doi.org/10.1371/journal.pbio.3000730.t002
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COVID-19 emergency and novel tests are starting to get approval for diagnostic use through
the FDA’s Emergency Use Authorisation (EUA) scheme [68], WHO’s Emergency Use Listing
and other national schemes [110]. The transparent and international sharing of protocols at
inter-agency level is capable of driving forward testing while academic and commercial proj-
ects catch up and apply for emergency approval status.
Community and commercial open source efforts in diagnostic technology to date have
focused on four areas: i) open platforms for scaling reactions as exemplified by Opentrons (Fig
3A) [28], an open source lab automation platform that has been working with BP Genomics
and the Open Medicine Institute to automate up to 2,400 tests per day and achieve US FDA
EUA approval and is now automating COVID-19 testing at the Biomedical Diagnostic Center
(CBD) of Hospital Clinic of Barcelona; ii) trying to fill gaps where less attention is being paid
by clinical diagnostics companies, such as Chia Bio’s Open qPCR (Fig 3B) environmental test
kit for surveillance via surface swabs [111]; iii) distributed reproduction of rapidly-published,
lab-scale protocols, seen within the OpenCOVID initiative hosted by Just One Giant Lab [39]
which involves many community labs worldwide; iv) initiatives such as the Open Enzyme Col-
lection [93], Free Genes [94] and Biomaker Challenge [112] which are investigating new
approaches to foundational technologies such as reagents and instrumentation, with a view to
building capacity and resources or global science and medicine to face a future pandemic.
These efforts supplement a wide range of existing open hardware and off-patent, generic
biotechnologies which could play a role in expanding molecular testing capabilities [7,113–
116].
In addition, a rapidly accumulating list of publications and pre-prints describe protocols
that allow bypassing some of the rate limiting steps in the diagnostic protocol [92,119–121].
For example, RNA extraction can be substituted by simply heating the sample to 95˚C for 10
minutes [92,121]. Furthermore, the development of alternative diagnostic techniques could
help bypass some of the hardware requirements. For example, recently published protocols
based on Cas enzymes [106,107,122], ligation-dependent detection [123] and colorimetric
RT-LAMP [124,125] obviate the need for a qPCR machine. These protocols require only
pipettes and heat blocks or water baths in terms of instrumentation. Readout can then be done
via inexpensive lateral flow strips, using a plate reader for which open hardware alternatives
exist [29], or even by eye. It is important to note that many of these alternative detection proto-
cols were only shown to work using DNA plasmid controls, or on very small numbers of
SARS-CoV-2 patient samples. Therefore, before these are adopted as bona fide diagnostic
Fig 3. Examples of FOSH designs with potential use in diagnostics. A, OpenTrons [28], a liquid handling robot B, Miriam, an incubator and reader
for isothermal amplifications e.g. LAMP [117]. C, US CDC Primer and Probe Kit for diagnostic tests [118].
https://doi.org/10.1371/journal.pbio.3000730.g003
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tests, they need to be thoroughly evaluated, followed by local regulatory approval (see above).
Companies are being particularly efficient at this [126], but government-funded labs are also
now testing and scaling protocols that are independent of commercial kits and this trend has
potential to overcome some of the more acute reagent supply chain issues.
Although most of these enzymes and protocols are patent-locked, they would be available
for manufacturing and use in areas where patents were not filed, which likely includes many
countries in the Global South. Local manufacturing of health technologies depends on the
presence of relevant capacity, infrastructure and regulatory frameworks but is promoted by
organisations including the WHO, UNIDO, UNCTAD, UNAIDS, UNICEF and The Global
Fund [127]. The implementation of low-cost diagnostic technologies in countries with very
limited testing resources could be a game changer in the global control of the COVID-19 pan-
demic, particularly when combined with protocols for RNA extraction that do not depend on
commercial kits ([90–92,119,121], and Table 3), and the generation of reagents that can be dis-
tributed and stored at room temperature [128]. For this reason, development of rapid diagnos-
tics for use at the community level was #1 in the WHO’s eight immediate research actions
agreed as part of their 2019 Novel Coronavirus Global Research and Innovation Forum [129].
The scientific community is coming together to find and implement faster and cheaper
diagnostics, which could be instrumental to control the pandemic, particularly in the medium
term amid fears of the so-called “second peak” if and when the strict isolation measures put in
place in many countries relax. The diagnostic supply chain issues we face currently highlight
the risks of under-investment in public diagnostic infrastructure and of vendor lock-in, result-
ing in reliance on a small number of suppliers. Efforts from the open hardware community to
design and produce rate-limiting equipment and reagents (Table 3, Fig 3) could offer a long-
term mitigation strategy, allowing rapid scale up of manufacturing of generic designs and reci-
pes, given sufficient political will and investment.
Conclusion and outlook
In the sections above, we have summarised a subset of current FOSH related initiatives aiming
to meet the global challenge of COVID-19. However, our account is by no means comprehen-
sive, and the situation changes daily. Accordingly it remains important to continuously seek
up to date information, for example by following live documents curated by the community
on various aspects of the FOSH response [33,37,130], and to join key community portals and
mailing lists [23,24,130–132].
For brevity, we omitted discussions of related approaches, for example the introduction and
modification of existing tools from veterinary care [133]. We did not discuss the important role
open-source software and data-collection initiatives can play in understanding and responding
to the ongoing and projected situation [134–136]. Also not covered here are other Open Science
tools and projects that could help alleviate many problems in the current scenario [137].
Most of the technology discussed above is classed as a medical device when used in a diag-
nostic or clinical setting; a challenge faced by only a small number of existing open hardware
devices and therefore in need of further research. Moving technology to implementation is
perhaps the greatest challenge facing these projects, involving consideration of integration into
health care systems, supply chain logistics, regulations, legal liability and political will. The
urgency of the current situation has led to a relaxation of regulatory processes by the US Food
and Drug Administration [138] and the European Union [139], with some open source proj-
ects already reaching formal testing stages e.g. the VentRap ventilator from the Open AIRE
forum is ready for evaluation by the Department of Health of the Principality of Asturias in
Spain [140].
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In conclusion, FOSH approaches are set to play an important part in the global response to
our current situation. To what extent they are able to scale a practical response that directly
addresses the current wave of need for medical and diagnostic hardware remains to be seen
but that is not their only valuable contribution: they are unlocking large and distributed pools
of talent, building knowledge, developing innovative designs and fostering capacity and capa-
bilities to tackle this crisis and future emergencies. Like open source software, FOSH works
through the eyes and brains of many. The more people join ongoing projects, or launch their
Table 3. Diagnostic hardware and reagents with open source alternatives. We have selected FDA/CDC-approved items as an illustration but each country will have its
own regulators and agencies with different sets of approved equipment and reagents. Many countries are choosing to simplify or accelerate regulatory approval during the
COVID-19 pandemic.
Item Selected examples of current CDC/FDA-approved items Status of Open Source alternatives
Note: these protocols and devices are not yet nationally approved for
diagnostic use in any jurisdiction at the time of writing but they might
be approved for use in specific labs and hospitals.
RNA Extraction Kit Qiagen QIAamp1 Viral RNA Mini Kit
Roche MagnaPURE Total Nucleic Acid Kit
There are numerous published protocols to extract viral RNA from
swabs using standard laboratory reagents, for example:
• Trizol and ethanol technique [90]
• Magnetic Bead-based extraction [91]
• Direct RT-PCR from crude samples [92]
qRT-PCR Mix Thermo Fisher Scientific1 TaqPath 1-Step RT-qPCR Master Mix Consists of multiple components:
Enzymes (e.g. MMLV reverse transcriptase and DNA polymerase) can
be produced in most labs from DNA vectors. Early versions are already
off-patent and sequences are available from the Open Enzyme
Collection [93] and Free Genes [94]. Later versions are patent-protected
in some jurisdictions but not all.
dNTPs require specific manufacturing capabilities and are currently
readily available commercially in bulk.
Buffers typically use standard lab chemicals and are often published but
may be proprietary.
Primers CDC Primer Set and others approved under FDA Emergency Use
Authorization [95]
Several primer designs have been published as open data and can be
synthesised commercially by any company but for diagnostic use the
company and reagent batches should be validated and approved by the
relevant local regulatory body or used in a regulated lab.
Positive Control
RNA/DNA
Positive controls are distributed with CDC kits by the International
Reagent Resource [96]. Genomic RNA positive control available
through BEI Resources [97].
SARS-COV-2 genome and control sequences are open data and can be
synthesised commercially by any company but must be approved for
diagnostic use. Control reagents are available from [98] in the US and
from relevant agencies or the WHO elsewhere.
Automated RNA
Extraction Platform
Qiagen EZ1 Advanced XL
Roche MagNA Pure LC
bioMe´rieux NucliSENS1 easyMAG1 Instrument
OpenTrons [28] is an open source automated platform that can work
with a variety of generic reagents.
qPCR Thermocycler Applied Biosystems 7500 Fast Dx Real-Time PCR System with SDS
version 1.4 software
Open qPCR [99] is partially open hardware. There are currently no fully
open alternatives.
Centrifuges Refrigerated high-speed centrifuge No open designs yet with suitable specifications. Existing centrifuge
designs [100–102] are usually designed for low-speed separation of
plasma at ambient temperature.
Centrifuges and compatible consumables are widely available from
generic manufacturers.
Heat block/Water
bath
Heat block/Water bath with 30–90˚C temperature range No open heat block designs yet, water baths have been described using
microcontrollers and immersion heaters but the simplest available
solution is use of a sous vide cooking device [103].
Heat blocks and water baths are widely available from generic
manufacturers.
Pipettes Adjustable micropipettes that meet ISO 8655 Standard in the range
0.5 μl to 1,000 μl
A 3D-printed open source design is available for an adjustable
micropipette that meets the ISO 8655 Standard down to 30 μl [104].
Note that this volume is not low enough for use in typical in vitro
diagnostic testing. Adjustable micropipettes and compatible
consumables are widely available from generic manufacturers.
https://doi.org/10.1371/journal.pbio.3000730.t003
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own and freely share their progress online, the faster and more effective our united global
community will be. The time to join is now.
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